MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by COSTA, M. R. C.
Right arrow Articles by BREAKEFIELD, X. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by COSTA, M. R. C.
Right arrow Articles by BREAKEFIELD, X. O.

Molecular Pharmacology, Vol 16, 242-249, Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics

Electrophoretic Characterization of Monoamine Oxidase by [3H]Pargyline Binding in Rat Hepatoma Cells with A and B Activity

MARIA R. CASTRO COSTA 1 and XANDRA O. BREAKEFIELD 1

1 Department of Human Genetics, Yale University School of Medicine New Haven, Connecticut 06510

[3H]Pargyline bound to active sites of both A and B types of monoamine oxidase (MAO) activity in a clonal line of rat hepatoma cells. Crude mitochondrial preparations were incubated with this drug, washed and solubilized, then electrophoresis was carried out in sodium dodecyl sulfate (SDS) polyacrylamide gels. At [3H]pargyline concentrations up to 2 nmoles/mg mitochondrial protein (0.8 µM), a single major protein species of molecular weight 57,000 was identified by autoradiography. The dose-dependent inhibition of labeling of this protein band by clorgyline and deprenyl was consistent with the presence of both A and B sites of MAO. Moreover, both A and B types of activity were inhibited under conditions giving saturated binding of [3H]pargyline to the 57,000 dalton protein Our results support the hypothesis that MAO activity resides in one protein or several proteins of similar molecular weight.

Note:
ACKNOWLEDGMENTS We thank Dr. John Casnellie for his excellent advice throughout this study; Drs. Dennis Murphy and Jonathan Costa for suggesting the use of radioactively labeled pargyline; and Ms. Lisa Poteet and Regina Gambardella for skilled preparation of the manuscript.

Submitted on November 3, 1978
Accepted on January 10, 1979







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1979 by the American Society for Pharmacology and Experimental Therapeutics